Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
Open Access
- 1 March 2002
- journal article
- review article
- Published by SAGE Publications in Cancer Control
- Vol. 9 (2), 123-137
- https://doi.org/10.1177/107327480200900205
Abstract
Patients with hematologic malignancies in relapse after allogeneic bone marrow transplantation can be treated by infusing leukocytes from the original stem cell donor.Keywords
This publication has 98 references indexed in Scilit:
- Graft-versus-myeloma effect in two casesThe Lancet, 1996
- Th1 and Th2 subsets: paradigms lost?Immunology Today, 1995
- Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1993
- A fail-safe mechanism for maintaining self-tolerance.The Journal of Experimental Medicine, 1992
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host diseaseNature, 1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivityNature, 1979
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- ATTEMPTED ADOPTIVE IMMUNOTHERAPY OF ACUTE LEUKÆMIA BY LEUCOCYTE TRANSFUSIONSThe Lancet, 1966